Febrile Neutropenia Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Febrile Neutropenia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.

Febrile Neutropenia
Shanxi Bethune Hospital20 enrolled1 locationNCT07204522
Recruiting
Phase 2

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital1,076 enrolled1 locationNCT07187908
Recruiting
Not Applicable

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

Febrile Neutropenia
Case Comprehensive Cancer Center30 enrolled1 locationNCT06657183
Recruiting

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Febrile Neutropenia
Boris Böll400 enrolled6 locationsNCT05815628
Recruiting
Phase 4

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Febrile Neutropenia
Beneficência Portuguesa de São Paulo176 enrolled1 locationNCT06342115
Recruiting
Phase 4

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

Chemotherapy-Induced Febrile Neutropenia
Qilu Pharmaceutical Co., Ltd.336 enrolled1 locationNCT06616571
Recruiting
Not Applicable

Short Antibiotic Treatment in High Risk Febrile Neutropenia

Febrile Neutropenia
University Health Network, Toronto80 enrolled4 locationsNCT05786495
Recruiting
Phase 4

Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance

Febrile Neutropenia
Centre Hospitalier Universitaire Vaudois30 enrolled1 locationNCT06293677
Recruiting

There is no place like home. Part 1. The Australian Predicting Infectious Complications in Children with Cancer (PICNICC) Project Part 2. National Scale Up of the Low Risk Febrile Neutropenia Program

Microbiologically Documented InfectionSepsisFebrile Neutropenia+1 more
Peter MacCallum Cancer Centre1,352 enrolled9 locationsACTRN12616001440415
Recruiting

Madu tualang' honey as prophylaxis against febrile neutropenia in patients with haematological malignancy

Febrile Neutropenia
Universiti Sains Malaysia135 enrolled1 locationACTRN12609000860268